The first Corcept Therapeutics trade was made in Q2 2004.
Since then Mario Gabelli bought shares five more times and sold shares on seven occasions. The investor completely sold their stake between Q3 2009 and Q1 2010.
Avg closing price
Price range
Sold -35 Thousand shares
Q1 2010
Avg closing price
$2.77
Price range
$2.51
-
$3.13
Sold 2.8% shares (-1 Thousand shares)
Q4 2009
Avg closing price
$2.17
Price range
$1.36
-
$2.90
Sold 50.0% shares (-36 Thousand shares)
Q3 2009
Avg closing price
$1.12
Price range
$0.76
-
$1.65
Increased shares by 89.5% (+34 Thousand shares)
Q2 2009
Avg closing price
$0.92
Price range
$0.77
-
$1.13
Sold 50.0% shares (-38 Thousand shares)
Q1 2009
Avg closing price
$1.05
Price range
$0.75
-
$1.35
Increased shares by 100.0% (+38 Thousand shares)
Q4 2008
Avg closing price
$1.23
Price range
$0.91
-
$1.65
Sold 52.5% shares (-42 Thousand shares)
Q1 2008
Avg closing price
$2.73
Price range
$2.44
-
$3.22
Increased shares by 81.8% (+36 Thousand shares)
Q4 2007
Avg closing price
$3.39
Price range
$2.67
-
$5.10
Sold 12.2% shares (-6.1 Thousand shares)
Q3 2007
Avg closing price
$2.93
Price range
$1.93
-
$4.90
Sold 16.5% shares (-9.9 Thousand shares)
Q2 2007
Avg closing price
$1.59
Price range
$1.10
-
$2.84
Increased shares by 100.0% (+30 Thousand shares)
Q4 2006
Avg closing price
$1.23
Price range
$1.23
-
$1.23
Increased shares by 100.0% (+15 Thousand shares)
Q2 2005